Tivic Health Systems (Nasdaq:TIVC) announced today that it completed enrollment in a study for its vagus nerve stimulation (VNS) device. The study, conducted by The Feinstein Institute of Bioelectronic Medicine, evaluates Tivic’s patent-pending, non-invasive VNS system. It aims to identify device parameters that optimally influence autonomic nervous system (ANS) function. These include the frequency and […]
tivichealth
Tivic Health regains Nasdaq compliance
Tivic Health (Nasdaq:TIVC) announced today that it regained compliance with the minimum bid price requirement on the Nasdaq market. Earlier this year, San Francisco-based Tivic filed an SEC Form 8-K pertaining to a notice of delisting from the Nasdaq market. The company received notice in January that its closing price fell below $1 for 30 […]
Tivic Health’s OTC sinus pain device wins FDA nod
Tivic Health Systems said that its ClearUP device for allergy-induced sinus pain has received 510(k) clearance from FDA. ClearUP is an over-the-counter device that provides consumers with a simple, non-invasive and drug-free option to relieve sinus pain caused by various environmental allergies such as dust, mold, pollens and pet dander, according to the […]
